Suzhou Lixin Pharmaceutical Co Ltd

China

http://www.szlxpharm.com/

Drug Substance

Excipients & Specialty Ingredients

Analytical & Bioanalytical Services

Clinical Trial Supply & Logistics

Contract Research Organization

Company Overview

About

Suzhou Lixin Pharmaceutical Co., Ltd. is a privately-owned Chinese GMP manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, established in 2000. The company produces APIs including semaglutide, sitagliptin phosphate, and indapamide, with multiple FDA-registered facilities that have been FDA-inspected.

Key Expertise

API and intermediate manufacturing, semaglutide, sitagliptin phosphate, small molecule API synthesis

Therapeutic Areas

Metabolic Disease

Cardiovascular

Quick Facts

HQ:China

Capabilities & Services

Core Capabilities

Small Molecule API
API Manufacturing
Process Development

Production Scales

Commercial Scale

Annual Capacity

Medium Clinical (100 - 1,000 kg/year)

Commercial (1,000 - 10,000 kg/year)

Markets Served

Asia

Manufacturing Facilities

1 site worldwide

Suzhou Lixin Pharmaceutical Co Ltd - China Facility

China

View on Map

Site Capabilities

Formulation Development

Process Development

Scale-up

Certifications

FDA Registration

U.S. Food and Drug Administration

NMPA (China)

National Medical Products Administration

Customer Reviews

No reviews available yet.

Company Documents

No documents available.

Send Inquiry

Please log in to send an inquiry to this CDMO.